Showing results (101-110 of 111) with videos related to
Sort By:
Pageof 12
Biorxiv : the Preprint Server for Biology|June 3, 2025
Increasing Stemness Drives Prostate Cancer Progression, Plasticity, Therapy Resistance and Poor Patient SurvivalXiaozhuo Liu, Eduardo Cortes, Yibing Ji, et al.Science (New York, N.Y.)|January 7, 2017
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancerPing Mu, Zeda Zhang, Matteo Benelli, et al.Nature Reviews. Cancer|June 3, 2025
Acquired resistance in cancer: towards targeted therapeutic strategiesAlice Soragni, Erik S Knudsen, Thomas N O'Connor, et al.Nature Communications|November 20, 2024
Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancerShankha S Chatterjee, Juan F Linares, Tania Cid-Diaz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2017
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer SubgroupDavid P Labbé, Christopher J Sweeney, Myles Brown, et al.Science (New York, N.Y.)|August 18, 2022
Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signalingJoseph M Chan, Samir Zaidi, Jillian R Love, et al.Cancer Cell|July 16, 2021
Binary pan-cancer classes with distinct vulnerabilities defined by pro- or anti-cancer YAP/TEAD activityJoel D Pearson, Katherine Huang, Marek Pacal, et al.The Journal of Pathology|October 18, 2023
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancerRadhika A Patel, Erolcan Sayar, Ilsa Coleman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2019
The Role of Lineage Plasticity in Prostate Cancer Therapy ResistanceHimisha Beltran, Andrew Hruszkewycz, Howard I Scher, et al.Biorxiv : the Preprint Server for Biology|April 22, 2024
Single Cell Analysis of Treatment-Resistant Prostate Cancer: Implications of Cell State Changes for Cell Surface Antigen Targeted TherapiesSamir Zaidi, Jooyoung Park, Joseph M Chan, et al.Pageof 12